Sudeep Pharma, one of the leading global manufacturers of mineral-based excipients and actives for pharmaceutical, food, and nutrition industries, has fixed the price band for its initial public offering (IPO) at Rs 563-593 per share, valuing itself close to Rs 6,700 crore at the higher end of the band.

The IPO is a combination of fresh issuance of shares worth Rs 95 crore and an offer-for-sale of 1.34 crore shares by promoters - the Bhayani family.

The company's Rs 895 crore IPO will open for the public on November 21 and close on November 25, while the anchor book will be launched for a day on November 20.

Investors can bid for a minimum of 25 equity shares and in multiples of 25 shares thereafter. The minimum investment by retail investors in the IPO would be Rs 14,825 for a lot of

See Full Page